NCT00003073View on ClinicalTrials.gov

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

PHASE1UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 1997

Conditions
Brain and Central Nervous System TumorsLeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

liposomal cytarabine

Trial Locations (6)

98105

Children's Hospital and Regional Medical Center - Seattle, Seattle

90027-0700

Children's Hospital Los Angeles, Los Angeles

94305-5408

Stanford University Medical Center, Stanford

75235-8897

University of Texas Southwestern Medical Center at Dallas, Dallas

77030-2399

Texas Children's Cancer Center, Houston

T2T 5C7

Alberta Children's Hospital, Calgary

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY

NCT00003073 - Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors | Biotech Hunter | Biotech Hunter